These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8322788)
1. Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients. Markell MS; Sumrani N; DiBenedetto A; Friedman EA Am J Kidney Dis; 1993 Jul; 22(1):233-9. PubMed ID: 8322788 [TBL] [Abstract][Full Text] [Related]
2. Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation. Aguilar-Salinas CA; Díaz-Polanco A; Quintana E; Macias N; Arellano A; Ramírez E; Ordóñez ML; Velásquez-Alva C; Gómez Pérez FJ; Alberú J; Correa-Rotter R Am J Kidney Dis; 2002 Jul; 40(1):169-77. PubMed ID: 12087575 [TBL] [Abstract][Full Text] [Related]
3. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods. Soylu A; Kavukçu S; Türkmen MA; Kasap B; Soylu A; Bora S; Gülay H Transplant Proc; 2006 Jun; 38(5):1286-9. PubMed ID: 16797283 [TBL] [Abstract][Full Text] [Related]
4. Hyperlipidemia after renal transplantation and its relation to graft and patient survival. Ramezani M; Einollahi B; Ahmadzad-Asl M; Nafar M; Pourfarziani V; Samadpour A; Moradi M; Alghasi M; Chalian H; Davoudi F Transplant Proc; 2007 May; 39(4):1044-7. PubMed ID: 17524887 [TBL] [Abstract][Full Text] [Related]
6. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus. Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552 [TBL] [Abstract][Full Text] [Related]
7. Impact of serum lipids on long-term graft and patient survival after renal transplantation. Bumgardner GL; Wilson GA; Tso PL; Henry ML; Elkhammas EA; Davies EA; Qiu W; Ferguson RM Transplantation; 1995 Dec; 60(12):1418-21. PubMed ID: 8545867 [TBL] [Abstract][Full Text] [Related]
8. The effects of hyperlipidaemia on graft and patient outcome in renal transplantation. Del Castillo D; Cruzado JM; Manel Díaz J; Beneyto Castelló I; Lauzurica Valdemoros R; Gómez Huertas E; Checa Andrés MD Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii67-71. PubMed ID: 15192140 [TBL] [Abstract][Full Text] [Related]
9. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. Sinclair NR CMAJ; 1992 Sep; 147(5):645-57. PubMed ID: 1521210 [TBL] [Abstract][Full Text] [Related]
10. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. Ichimaru N; Takahara S; Kokado Y; Wang JD; Hatori M; Kameoka H; Inoue T; Okuyama A Atherosclerosis; 2001 Oct; 158(2):417-23. PubMed ID: 11583721 [TBL] [Abstract][Full Text] [Related]
11. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224 [TBL] [Abstract][Full Text] [Related]
12. Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation. Spinelli GA; Felipe CR; Machado PG; Garcia R; Casarini DE; Moreira SR; Park SI; Tedesco-Silva H; Medina-Pestana JO Braz J Med Biol Res; 2006 Jan; 39(1):19-30. PubMed ID: 16400461 [TBL] [Abstract][Full Text] [Related]
14. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function. Sumrani N; Delaney V; Ding ZK; Butt K; Hong J Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931 [TBL] [Abstract][Full Text] [Related]
15. Long-term renal function in cyclosporine-treated renal allograft recipients. Tanabe K; Novick AC; Streem S; Hodge E Urology; 1995 Sep; 46(3):321-7. PubMed ID: 7660506 [TBL] [Abstract][Full Text] [Related]
16. Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Gisbert C; Prieto M; Berenguer M; Bretó M; Carrasco D; de Juan M; Mir J; Berenguer J Liver Transpl Surg; 1997 Jul; 3(4):416-22. PubMed ID: 9346772 [TBL] [Abstract][Full Text] [Related]
17. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients. Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
19. A long-term study on hyperlipidemia in stable renal transplant recipients. Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk profile in nondiabetic renal transplant patients: cyclosporine versus tacrolimus. Hernández D; Alvarez A; Torres A; Oppenheimer F; Cobo M; González-Posada J; Jiménez A; Lorenzo V; Torregrosa V Transplant Proc; 2003 Aug; 35(5):1727-9. PubMed ID: 12962773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]